Innovating Works

METATISSUE

MITI 2: Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2) METATISSUE BIOSOLUTIONS LDA participó en un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Our project focuses on the regulatory properties of a subset of microbiota-specific TR1-like regulatory T (Treg) cells, for which we have al...
2023-04-28 - 2027-04-30 | Financiado
BioRobot-MiniHeart: Engineering a living human Mini-heart and a swimming Bio-robot METATISSUE BIOSOLUTIONS LDA participó en un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01 Cardiovascular disease (CVD) is still the N1 cause of death worldwide despite the significant efforts of academia and pharmaceutical industr...
2022-06-23 - 2027-10-31 | Financiado
TheraTools: Innovative tools to treat and model complex cancer environments METATISSUE BIOSOLUTIONS LDA participó en un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 TheraTools has arisen as a multidisciplinary research and training network that encompasses a full academical and technological view of the...
2022-06-02 - 2026-12-31 | Financiado
TechTissue: TechTissue - Validate human-based 3D in vitro models for accurate drug discovery and development tow... METATISSUE BIOSOLUTIONS LDA tramitó un HORIZON EUROPE: HORIZON-EIE-2021-SCALEUP-01 Metatissue is focused on the design, production and commercialization of chemically modified human-derived proteins to prepare hydrogels, sp...
2022-05-16 - 2023-05-31 | Financiado
UroPrint: Urinary bladder bioprinting for fully autologous transplantation METATISSUE BIOSOLUTIONS LDA participó en un H2020: H2020-FETOPEN-2018-2020 A number of conditions, including trauma, inflammation, incontinence, overactive bladder, renal impairments, neurological disorders (like sp...
2021-03-12 - 2025-08-31 | Financiado
InterLynk: Human Platelet Lysates based Scaffolds for Interfacial Multi tissue Repair METATISSUE BIOSOLUTIONS LDA participó en un H2020: H2020-NMBP-TR-IND-2018-2020 InterLynk aims to develop multi-tissue 3D patient-specific scaffolds by providing a portfolio of highly compatible and biofunctional composi...
2020-12-02 - 2025-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.